Amol Pharmaceuticals Private Limited, a active private limited company, was established on 12 February 1996 in Jaipur, Rajasthan, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24230RJ1996PTC097657. Registered under ROC Roc Jaipur. it is unlisted. It has an authorized capital of ₹7.50 M and a paid-up capital of ₹6.65 M.
It upholds a compliant status. Employing 316 professional, Its leadership includes Sandeep Sapra (Managing Director), Ashok Luhadia (Director). Past directors included Shobha Luhadia, Dhanpatrai Luhadia, Sonali Luhadia. It holds ₹48.46 Cr open charges and ₹36.74 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at E-1, 362-363-364, Sanganer, Jaipur, Rajasthan, 302022.
U24230RJ1996PTC097657
097657
12 February 1996
₹7.50 M
₹6.65 M
Roc Jaipur
Unlisted
Active
Explore comprehensive insights into Amol Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sandeep Sapra | Managing Director | 01 Mar 1996 | Current |
| Ashok Luhadia | Director | 12 Feb 1996 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 30 Sep 2013 | Past |
| Pramod Abcsdd | Director | 30 Sep 2013 | Past |
| Pramod Abcsdd | Director | 30 Sep 2013 | Past |
| Pramod Abcsdd | Director | 01 Apr 2013 | Past |
| Pramod Abcsdd | Director | 03 Jul 2023 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Amol Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 10.53% increase. The company also saw a substantial fall in profitability, with a 18.23% decrease in profit. The company's net worth Soared by an impressive increase of 15.6%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Amol Pharmaceuticals had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹484,630,100.00
₹367,392,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Apr 2024 | Others | ₹9.63 M | Open |
| 23 Dec 2020 | Hdfc Bank Limited | ₹47.50 Cr | Open |
| 22 Jul 2020 | State Bank Of India | ₹4.13 Cr | Satisfied |
| 07 Apr 2020 | State Bank Of India | ₹2.40 Cr | Satisfied |
| 10 Feb 1997 | State Bank Of India | ₹29.46 Cr | Satisfied |
Explore comprehensive loan charge details -
Amol Pharmaceuticals has a workforce of 316 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Amol Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Amol Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge with Hdfc Bank Limited of Rs. 475.00 M registered on 23 Dec 2020 with Charge ID 100411737 was modified on 24 Mar 2025. was recorded as a recent event.
Amol Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
The activity A charge with Others amounted to Rs. 9.63 M with Charge ID 100911310 was registered on 20 Apr 2024. was completed.
Amol Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Jaipur. was recorded as a recent event.
A charge registered on 22 Jul 2020 via Charge ID 100362597 with State Bank Of India was fully satisfied on 01 Jun 2021. was recorded as a recent event.
The activity A charge registered on 07 Apr 2020 via Charge ID 100333081 with State Bank Of India was fully satisfied on 01 Jun 2021. was completed.
The CIN of Amol Pharmaceuticals Private Limited is U24230RJ1996PTC097657.
Amol Pharmaceuticals Private Limited is headquartered at E-1, 362-363-364, Sanganer, Jaipur, Rajasthan, 302022.
Amol Pharmaceuticals Private Limited was incorporated on 12 February 1996.
The current directors of Amol Pharmaceuticals Private Limited are
The primary industry of Amol Pharmaceuticals Private Limited is Manufacturing.
Amol Pharmaceuticals Private Limited is unlisted.
The authorized capital of Amol Pharmaceuticals Private Limited is ₹7.50 M, and the paid-up capital is ₹6.65 M.
The compliance status of Amol Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX